Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€213.80
18.01.22
€350.00
18.01.23
47.33%
23.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€192.48
12.01.22
€240.00
12.01.23
-0.52%
16.02.22

Could be worthwhile Investment >10% per year
Known brand
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.22
12.01.22
€240.00
12.01.23
-0.90%
12.01.22

Could be worthwhile Investment >10% per year
Known brand
Illumina Inc.

Start price
Target price
Perf. (%)
€364.50
11.01.22
-
11.01.23
-8.29%
21.01.22

Probably not worthwhile Investment
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
112.73%
20:54

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.01
03.01.22
€78.00
03.01.23
-2.98%
04.01.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€149.96
28.12.21
-
28.12.22
10.44%
29.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€52.51
22.12.21
€55.00
22.12.22
-7.45%
23.12.22

Could be worthwhile Investment >10% per year
Johnson & Johnson

Start price
Target price
Perf. (%)
€147.94
22.12.21
-
22.12.25
1.31%
28.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.36
06.12.21
€60.00
06.12.22
-0.12%
06.12.22

Could be worthwhile Investment >10% per year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€533.60
09.11.21
€600.00
09.11.22
38.91%
10.11.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€524.70
08.11.21
-
08.11.22
10.50%
21.07.22

Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.70
05.11.21
€60.00
31.12.23
28.01%
24.08.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€42.04
05.11.21
€70.00
31.12.24
11.00%
02.09.22

Could be worthwhile Investment >10% per year
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€167.78
04.11.21
€300.00
04.11.22
63.28%
28.06.22

Could be very worthwhile Investment >20% year
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.76
26.10.21
€65.00
26.10.22
38.64%
27.10.22

Could be worthwhile Investment >10% per year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€390.10
20.10.21
€460.00
31.12.23
25.56%
01.09.22

Could be very worthwhile Investment >20% year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€373.45
20.10.21
€450.00
31.12.23
28.49%
28.06.22

Could be very worthwhile Investment >20% year
buy
Anthem Inc.

Start price
Target price
Perf. (%)
€363.90
20.10.21
€400.00
31.12.23
26.90%
28.06.22

Could be very worthwhile Investment >20% year